Acquiring Company
Quanterix
Acquired Company
Akoya Biosciences
BillericaMarlboroughOtherHealth CareOtherBiotechnologyHealth CareGeneticsHealth DiagnosticsBioinformaticsDescription
Quanterix Corporation is set to merge with Akoya Biosciences, following the expiration of regulatory waiting periods. Akoya shareholders will receive 0.318 shares of Quanterix for each share held. This merger aims to create significant synergies, with projected annual cost savings of $40 million by 2026. Despite opposition from a major shareholder, the deal is expected to strengthen Quanterix's technology capabilities.
Quick answer
Quanterix is acquiring Akoya Biosciences, announced March 18, 2025. Quanterix is based in Billerica, Massachusetts, United States.
- How much did Quanterix pay for Akoya Biosciences?
- The deal value was not disclosed.
- What does Quanterix do?
- Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health.
- Where are Quanterix and Akoya Biosciences based?
- Quanterix is based in Billerica, Massachusetts, United States. Akoya Biosciences is based in Marlborough, Massachusetts, United States.
- Who are the decision-makers at Quanterix?
- Fundz holds 1 contact at Quanterix. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Genetics and Health Diagnostics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Quanterix to acquire Akoya Biosciences shares (April 28, 2025)
- Quanterix to acquire Akoya Biosciences in stock deal (March 5, 2025)
- Quanterix Corporation moves forward with the acquisition of Akoya Biosciences, Inc. to create an integrated solution for protein biomarker detection (February 25, 2025)
- Premier Biotech acquires OraSure's testing line (April 10, 2025)
- Hikma acquires ANDA for trametinib from Novugen (April 17, 2025)
- AbbVie to acquire Cerevel for $45 per share (April 15, 2025)
Who to call at Quanterix, and when
When Quanterix changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Quanterix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Quanterix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Quanterix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Quanterix makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Akoya Biosciences?
Akoya Biosciences was acquired by Quanterix, based in Billerica. The deal was reported on March 18, 2025. Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. Quanterix is publicly traded (QTRX) and operates in Other.
When did Quanterix acquire Akoya Biosciences?
Quanterix's acquisition of Akoya Biosciences was reported on March 18, 2025. Quanterix Corporation is set to merge with Akoya Biosciences, following the expiration of regulatory waiting periods. Akoya shareholders will receive 0.318 shares of Quanterix for each share held. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Akoya Biosciences do?
Akoya Biosciences is The Spatial Biology Company®, dedicated to advancing human health by providing spatial phenotyping solutions that bring biological context to life. It is privately held, operating in Other, and is based in Marlborough.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.